Adtralza 150mg/ml, Injektionslösung in einer Fertigspritze

7680682290017 CH-68229 Injektionslösung

Associated product:

ADTRALZA sol inj 150 mg/ml ser pré 2 x 2 pce
Adtralza 150mg/ml, Injektionslösung in einer Fertigspritze
Adtralza 150mg/ml, Injektionslösung in einer Fertigspritze
Adtralza 150mg/ml, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
4
Selling units
4
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/11/2023
Patient information leaflet
Français
16/11/2023
Patient information leaflet
Italien
16/11/2023
Summary of Product Characteristics
Allemand
16/11/2023
Summary of Product Characteristics
Français
16/11/2023
Summary of Product Characteristics
Italien
16/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.977 MG Substance HBESI

Reimbursement information

Public price
CHF 1121.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2022

Authorization holder

Leo Pharmaceutical Products Sarath Ltd.

8302 Kloten

Authorization information

Swissmedic authorization number
68229
Drug name
Adtralza, Injektionslösung in einer Fertigspritze
Galenic form
LSINJ
ATC Code
D11AH07
Authorization status
Z
Dispensing category
B
First authorization
24/02/2022
Authorization expiration date
23/02/2027
IT Number
07.15.0.
Domain
Human medicine
Field of application
Behandlung von mittlerer bis schwerer atopischer Dermatitis von Erwachsenen, welche eine systemische Therapie benötigen

Package details

Description (FR)
ADTRALZA sol inj 150 mg/ml ser pré 2 x 2 pce
Description (DE)
ADTRALZA Inj Lös 150 mg/ml Fertspr 2 x 2 Stk
Market launch
24/02/2022
Narcotic (BTM)
No